Health2 min read
Millions of Americans are not taking their GLP-1 drugs as prescribed
Cost and access barriers are pushing people to modified use and unapproved versions.
By Beth MoleArs Technica

Read the full story
Originally published by Ars Technica on Nov 13, 2026.
Comments
Sign in to join the discussion.